Abstract.
Presenilin 1 (PS1) is mutated in the majority of familial cases of Alzheimer disease (AD). Although it is clear that PS1 is involved in the processing of the amyloid precursor protein (APP), the exact function of PS1 is still elusive. Human presenilin 1 (PS1) is alternatively spliced, resulting in the presence or absence of a four-amino acid motif, VRSQ, in the PS1 N-terminus. In human tissues, both isoforms are expressed. Here we report that mouse and rat only express the longer PS1 isoform. The presence of this motif introduces a potential phosphorylation site for protein kinase C. Because the splice occurs in the region of PS1 that we have previously shown to bind to rabGDI, this might provide a regulatory mechanism for this interaction. Our data show that the –VRSQ isoform binds rabGDI, but the +VRSQ does not. Moreover, mutation of the putatively phosphorylated threonine in PS1 disrupts the binding to rabGDI, showing its importance for the interaction. To our knowledge this is the first study showing a functional difference between PS1 splice variants. The possible consequences for APP processing and the pathogenesis of AD are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, Podlisny M, Selkoe DJ, Seeger M, Gandy SE, Price DL., Sisodia SS (1996) Protein topology of presenilin 1. Neuron 17:1023–1030
Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17:181–190
Capell A, Grunberg J, Pesold B, Diehlmann A,Citron M, Nixon R, Beyreuther K, Selkoe DJ, Haass C (1998) The proteolytic fragments of the Alzheimer’s disease-associated presenilin-1 form heterodimers and occur as a 100–150-kDa molecular mass complex. J Biol Chem 273:3205–3211
De Strooper B, Annaert W (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113:1857–1870
Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW (1997) Alzheimer’s A beta(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2 N cells. Nat Med 3:1021–1023
Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer’s disease A beta40/42 amyloid peptides. Nat Med 3:1016–1020
Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisodia SS (1996) Metabolism of the “Swedish” amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the “beta-secretase” site occurs in the Golgi apparatus. J Biol Chem 271:9390–9397
Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy–Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S.(1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2:864–870
De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387–390
De Strooper B (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron 38:9–12
Scheper W, Zwart R, Van der Sluijs P, Annaert W, Van Gool WA, Baas F(2000) Alzheimer’s presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor. Hum Mol Genet 9:303–310
D’Adamo P, Menegon A, Lo Nigro C, Grasso M, Gulisano M, Tamanini F, Bienvenu T, Gedeon AK, Oostra B, Wu SK, Tandon A, Valtorta F, Balch WE, Chelly J, Toniolo D (1998) Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet 19:134–139
Rogaev EI, Sherrington R, Wu C, Levesque G, Liang Y, Rogaeva EA, Ikeda M, Holman K, Lin C, Lukiw WJ, Jong PJ de, Fraser PE, Rommens JM, St George-Hyslop P (1997) Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 40:415–424
Calenda A, Mestre-Frances N, Czech C, Pradier L, Petter A, Bons N, Bellis M (1996) Molecular cloning, sequencing, and brain expression of the presenilin 1 gene in Microcebus murinus. Biochem Biophys Res Commun 228:430–439
Novick P, Zerial M (1997) The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 9:496–504
Pfeffer SR, Dirac-Svejstrup AB, Soldati T (1995) Rab GDP dissociation inhibitor: putting rab GTPases in the right place. J Biol Chem 270:17057–17059
Shisheva A, Buxton J, Czech MP (1994) Differential intracellular localizations of GDP dissociation inhibitor isoforms. Insulin-dependent redistribution of GDP dissociation inhibitor-2 in 3T3-L1 adipocytes. J Biol Chem 269:23865–23868
Nitsch RM, Slack BE, Farber SA, Schulz JG, Deng M, Kim C, Borghesani PR, Korver W, Wurtman RJ, Growdon JH (1994) Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer’s disease in transfected cell lines and in brain slices. J. Neural Transm [Suppl] 44:21–27
Shin JE, Koh JY, Mook-Jung I (1999) Presenilin 1 mediates protein kinase C dependent alpha-secretase derived amyloid precursor protein secretion and mitogen-activated protein kinase activation in presenilin 1 transfected human embryonic kidney 293 cell. Neurosci Lett 269:99–102
Scheper W, Zwart R, Baas F (2004) Rab6 membrane association is mediated by Presenilin 1 and cellular phosphorylation events. Mol Brain Res 122:17–23
Grima B, Lamouroux A, Boni C, Julien J-F, Javoy-Agid F, Mallet J (1987) A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326:707–711
Bateson AN, Lasham A, Darlison MG (1991) γ-Aminobutyric acid A receptor heterogeneity is increased by alternative splicing of a novel β-subunit gene transcript. J Neurochem 56:1437–1440
Morgan D (2003) Learning and memory deficits in APP transgenic mouse models of amyloid deposition. Neurochem Res 7:1029–1034
Isoe-Wada K, Urakami K, Wakutani Y, Adachi Y, Arai H, Sasaki H, Nakashima K (1999) Alteration in brain presenilin-1 mRNA expression in sporadic Alzheimer’s disease. Eur J Neurol 6:163–167
Barton AJ, Crook BW, Karran EH, Brown F, Dewar D, Mann DM, Pearson RC, Graham DI, Hardy J, Hutton M, Duff K, Goate AM, Clark RF, Roberts GW (1996) Alteration in brain presenilin 1 mRNA expression in early onset familial Alzheimer’s disease. Neurodegeneration 5:213–218
Acknowledgements.
We thank Dr. S. Niclou (Netherlands Institute for Brain Research, Amsterdam, The Netherlands) and Dr. A. ten Asbroek for rat and mouse tissues respectively, our co-workers at the Neurogenetics Laboratory for their support, and Jeroen Hoozemans for critical reading of the manuscript. This work is supported by the Internationale Stichting Alzheimer Onderzoek (ISAO grant 0254 to W.S.). W.S. is a fellow of the Anton Meelmeijer Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scheper, W., Zwart, R. & Baas, F. Alternative splicing in the N-terminus of Alzheimer’s presenilin 1. Neurogenetics 5, 223–227 (2004). https://doi.org/10.1007/s10048-004-0195-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-004-0195-y